Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group.
about
Neglected parasitic infections in the United States: toxoplasmosisPrevalence of Toxoplasma gondii among Iranian Blood Donors: A Narrative Review ArticleResults of the National External Quality Assessment for Toxoplasmosis Serological Testing in ChinaInfluenza M1 Virus-Like Particles Consisting of Toxoplasma gondii Rhoptry Protein 4Cardiac involvement with parasitic infections.VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassayDetection of immunoglobulin M antibodies to P35 antigen of Toxoplasma gondii for serodiagnosis of recently acquired infection in pregnant women.Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigenSerodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens.Comparison of immulite with vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands.Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.Use of dense granule antigen GRA6 in an immunoglobulin G avidity test to exclude acute Toxoplasma gondii infection during pregnancy.Obstetrician-gynecologists and perinatal infections: a review of studies of the Collaborative Ambulatory Research Network (2005-2009).Toxoplasmosis during pregnancy.Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.Identification of Toxoplasma gondii SUB1 antigen as a marker for acute infection by use of an innovative evaluation method.Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant womenSurvey of obstetrician-gynecologists in the United States about toxoplasmosisrROP2(186-533): a novel peptide antigen for detection of IgM antibodies against Toxoplasma gondiiMolecular diagnosis of Toxoplasma gondii infection in Libya.Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States.Survey of obstetrician-gynecologists in the United States about toxoplasmosis: 2012 update.Evaluation of Recombinant SAG1 Protein for Detection of Toxoplasma gondii Specific Immunoglobulin M by ELISA Test.Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and salivaComparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newbornsChallenges in diagnosis, treatment and follow-up of patients presenting with central nervous system infections in a resource-limited setting.Expression and Purification of Recombinant ROP1 of Toxoplasma gondii in Bacteria.Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studiesSerologic Detection of Anti Toxoplasma gondii Infection in Diabetic Patients.Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy.Detection of immunoglobulin M antibodies specific for Toxoplasma gondii with increased selectivity for recently acquired infections.Fast dipstick dye immunoassay for detection of immunoglobulin G (IgG) and IgM antibodies of human toxoplasmosis.Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.Contribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria.Toxoplasma gondii Infection in the United States, 2011-2014.Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.
P2860
Q22305416-2AE007D4-4EFB-41D3-B552-6594A5A63361Q26751862-64F45C6E-24DD-4C0B-8FE7-E0D4C8AB0DC1Q28548298-CEEEF886-F12E-41A7-A404-4B26DB629C5CQ33745539-106E47E0-D6A4-448D-80E2-5790B8274465Q33825602-D71A4A55-4A42-47AA-85B3-27D8A72BA3E1Q33961017-B94A76E9-D8E1-46ED-8469-E56C8ED81192Q33966031-9B8F3288-0BE9-4A5A-9B93-01B3195B236BQ33970177-74F4059A-F298-4316-B852-DD654D83534CQ33974763-BF4565F2-D353-4076-9F8B-E4888A66010EQ33998614-564BC08F-BF93-4016-937F-58F9B20580AAQ33999112-8091D32E-A454-4495-9216-15034322A000Q34043532-1B71CCA0-AF3F-4FDF-B3CC-DF53754DC45DQ34150450-3799B71E-C077-4E4A-B95A-9D8D6C45338BQ34338718-6F9CEAFA-4303-4AC2-8A83-045FFC7EF9C7Q34683901-21AC330A-EA33-4CDE-AD70-0AA583EF4626Q34719649-13D95FC9-A44B-4CA8-91A9-62101444C144Q35140142-DEF4EACE-E865-4DD0-A187-676475351093Q35523413-97FC87A4-817D-46A8-AC36-E7C501CC8C16Q35614793-C4AD2E7F-DE62-4077-B678-31BD30224A27Q35649358-6E1D1CB4-1980-49C7-A03C-C13D51AEE102Q35991241-815C4623-2904-46D4-B06C-D5CD3B7C0DF2Q36173989-1842D5D0-E63A-4F02-9419-90197E03AE7BQ36482662-C9205518-1DE3-4069-85B1-82379CDEA5BFQ36509899-7A954DAB-6E2A-4A6A-99F7-461D299A58B0Q36757805-B0E30375-9C56-4382-9987-88E77495B020Q37124736-934CFCEC-BAF4-4C08-82ED-92BC059E3444Q37206194-E12C42A9-7526-4971-B09E-7252DD1D6DE9Q37338084-F6B255C9-6D78-44FC-BFFD-348FF08CAC7FQ37469581-DAE85D54-8B00-4090-8FC2-CD53210BF653Q37569174-D83459DD-FEE4-4019-880F-16F02E5E6FA7Q37576269-659436EC-E195-44A8-B494-C2394DCB1B9FQ37702723-F06C2892-78DA-48E8-9C19-65076BE24228Q40772882-42E40C55-F787-4901-A56E-3A4DC669AB8BQ41141886-C3D13942-A67B-49CA-AB05-8A8AFAE9875AQ47129110-7861E1C1-8CD6-40A2-9C56-DC3FE9594ED4Q47188827-CED22759-5600-46A7-A175-7F5116B1C9E0Q49693679-9A157AC5-9D39-4308-984A-5A97DE270B78
P2860
Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Evaluation of six commercial k ...... lasmosis Ad Hoc Working Group.
@ast
Evaluation of six commercial k ...... lasmosis Ad Hoc Working Group.
@en
type
label
Evaluation of six commercial k ...... lasmosis Ad Hoc Working Group.
@ast
Evaluation of six commercial k ...... lasmosis Ad Hoc Working Group.
@en
prefLabel
Evaluation of six commercial k ...... lasmosis Ad Hoc Working Group.
@ast
Evaluation of six commercial k ...... lasmosis Ad Hoc Working Group.
@en
P2093
P2860
P921
P1476
Evaluation of six commercial k ...... plasmosis Ad Hoc Working Group
@en
P2093
P2860
P304
P407
P577
1997-12-01T00:00:00Z